Abstract:Purpose: The antioxidant resveratrol (RSV) has low bioavailability and can reach the colon to access the gut microbial ecosystem. RSV administration together with high-fat diet prevented abnormal changes of intestinal microbiota. However, whether or not RSV can reshape the intestinal microbiota of obese mice and alleviate obesity-related diseases remains to be studied. This study aimed to explore the role of RSV in alleviating high-fat-induced obesity and its relationship with oxidative stress and gut microbiota. Methods: Male C57BL/6 mice were divided into five groups and administered for 16 weeks with: standard diet (CON), high-fat diet (60% energy for lard, HFD), and HFD with low, medium, and high dose of RSV, 50, 75, and 100 mg/kg body weight administered daily via drinking water, respectively. Results: Medium and high RSV treatment significantly prevented body weight gain, decreased relative weight of liver and adipose tissue compared with HFD (P<0.05). All doses significantly prevented HFD-induced increase of serum triglyceride, low density lipoprotein cholesterol, glucose, and endotoxemia (P<0.05). Medium and high dose also prevented chronic inflammation by decreasing serum interleukin-1 and tumor necrosis factor-alpha (P<0.05), and oxidative stress in liver and brain indicated by increase in superoxide dismutase, catalase, glutathione peroxidase activity (P<0.05). Formation of malondialdehyde was prevented by all doses compared with HFD (P<0.05). Both medium and high doses of RES increased alpha diversity of gut microbiota according to the Chao1 and Shannon indices (P<0.05). Medium dose induced obvious shift in gut microbiota composition according to principal component analysis. High dose of RSV effectively prevented HFD-induced increase of Coriobacteriaceae and Desulfovibrionaceae (P<0.05), which show a significant correlation with body weight (r>0.8 P<0.00). Conclusion: RSV prevented HFD-induced endotoxemia, oxidative stress, and gut microbiota change.

Resveratrol Protects Against Renal Damage Via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice

The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression

Resveratrol Mitigates High-Fat Diet-Induced Vascular Dysfunction by Activating the Akt/eNOS/NO and Sirt1/ER Pathway

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice.

Resveratrol Protects Against High-Fat Diet Induced Renal Pathological Damage and Cell Senescence by Activating SIRT1.

Resveratrol Ameliorates Metabolic Disorders and Insulin Resistance in High-Fat Diet-Fed Mice.

Resveratrol affects the expression of uric acid transporter by improving inflammation

Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet.

The anti-inflammatory activity of resveratrol in acute kidney injury: a systematic review and meta‐analysis of animal studies

Protective Effects of Dietary Resveratrol against Chronic Low-Grade Inflammation Mediated through the Gut Microbiota in High-Fat Diet Mice

Resveratrol Prevents Suppression of Regulatory T-cell Production, Oxidative Stress, and Inflammation of Mice Prone or Resistant to High-Fat Diet–induced Obesity

Resveratrol-induced Gut Microbiota Reduces Obesity in High-Fat Diet-Fed Mice.

Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota

Renal Protection of Resveratrol in Rats with High-Fat Diet*

Effects of Resveratrol on Redox State of Adipose Tissue and Lipid of Mice Fed with High-fat Diet

Resveratrol Prevention of Diabetic Nephropathy is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway

Resveratrol Ameliorates Early Diabetic Nephropathy Associated with Suppression of Augmented TGF-β/smad and ERK1/2 Signaling in Streptozotocin-Induced Diabetic Rats.

Resveratrol Alleviates Obesity-Associated Podocyte Injury in Ovariectomized Obese Rats

Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: protection by chronic oral intake of resveratrol

Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction

Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury